ArticleCureus2026
Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Eosinophilic Granulomatosis With Polyangiitis Presenting With Refractory Asthma, Mononeuritis Multiplex, and Cutaneous Vasculitis: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis characterised by asthma, eosinophilia, and eosinophil-rich tissue inflammation. Early diagnosis is often difficult because initial features may resemble uncontrolled asthma or other eosinophilic lung diseases. We report a 66-year-old man with adult-onset asthma who presented with four months of progressive dyspnoea, constitutional symptoms, peripheral neuropathy, and cutaneous vasculitis. Investigations showed marked eosinophilia (19.1 × 10⁹/L), raised inflammatory markers, elevated creatine kinase and lactate dehydrogenase, and markedly elevated IgG4. Cross-sectional imaging showed calcified mediastinal and hilar lymph nodes without pulmonary infiltrates. Extensive infectious and haematological investigations were unrevealing. Anti-myeloperoxidase antibodies were positive, and skin biopsy confirmed small-vessel vasculitis with eosinophilic infiltration. A diagnosis of ANCA-positive EGPA was made. The patient was treated with high-dose corticosteroids, but symptom recurrence during steroid taper prompted escalation to intravenous cyclophosphamide for organ-threatening neurological involvement. This case highlights the importance of considering EGPA in patients with refractory asthma, eosinophilia, and systemic features even in the absence of pulmonary infiltrates. Early recognition and multidisciplinary management are essential to reduce irreversible organ damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.